Daily Bulletin


  • Written by Tracey Varker, Senior research fellow, Phoenix Australia, Department of Psychiatry, University of Melbourne

Can psychoactive drugs be used to treat mental health problems? The idea has been around for years, and recently received some attention in the media.

Interest in the potential of drugs such as MDMA (scientific name 3,4-methylenedioxymethamphetamine), ketamine, psilocybin and LSD (lysergic acid diethylamide) has been growing among scientists and doctors, as well as the wider community.

However, there is still debate among experts about whether these drugs are safe and effective. In a new study, we reviewed the state of the evidence for using these drugs in the treatment of post-traumatic stress disorder (PTSD).

How PTSD is treated now

Up to 10% of people who are exposed to traumatic events such as a serious accident, physical assault, war, natural disaster, sexual assault or abuse will develop PTSD. Symptoms can include reliving the event through unwanted thoughts, flashbacks or nightmares; feeling wound up, having trouble sleeping, concentrating or being on the lookout for danger; and avoiding reminders of the event. These symptoms may last for years if left untreated.

Read more: Explainer: what is post-traumatic stress disorder?

Psychotherapies such as trauma-focused cognitive behavioural therapy (CBT) and eye movement desensitisation and reprocessing (EMDR) therapy are first-line treatments for PTSD. These types of treatments involve teaching patients to confront and come to terms with the painful memories, thoughts and images they have been avoiding. They also provide patients with tools to get back into the activities or places they have been avoiding, and to relax when they start to feel wound up.

While there is strong evidence showing these treatments are effective, not everyone responds to them. Psychoactive drugs are often touted as the solution to this problem. But does the science match the hype?

What do we already know about psychoactive drugs for PTSD?

Ketamine, MDMA, LSD and psilocybin have all been considered as potential treatments for PTSD:

  • ketamine was developed as a general anaesthetic but is used recreationally because of its psychedelic and hallucinogenic properties. It acts mainly on the glutamergic system, which regulates large regions of the nervous system and has been implicated in the formation of traumatic memories and reduction of the stress response

  • MDMA is a synthetic compound and is typically the main constituent of “ecstasy”. It induces changes in human emotion and it is possible that MDMA, in combination with psychotherapy, can increase a person’s ability to access and process painful or negative emotions, and increase positive emotions and social interactions

Read more: Is psychiatry ready for medical MDMA?

  • LSD is a hallucinogen that produces psychosensory changes and alters cognition, often increasing optimism and inducing a sense of well-being. By increasing prosocial behaviour, it may strengthen the alliance between therapist and patient and so increase the effectiveness of psychotherapy. It can also encourage catharsis and relaxation

  • psilocybin naturally occurs in “magic mushrooms” and, like LSD, it increases a person’s sense of optimism and well-being and reduces negative mood. It can also be associated with increased capacity for introspection, and research studies have found it can reduce levels of anxiety and depression in cancer patients.

But do these drugs make a real difference in resolving PTSD symptoms? And are they any better than the treatments that we already have?

What does the latest evidence say?

To find out what the current evidence says, my colleagues and I at Phoenix Australia conducted a systematic review of the published research.

We found two small randomised trials in which ketamine was used in combination with psychotherapy to treat PTSD. Overall, we found ketamine shows some promise when compared with placebo, but future research is needed to investigate how ketamine, in combination with psychotherapy, stacks up against standard PTSD treatment.

The effect of using MDMA with psychotherapy was a little more encouraging, with four small randomised trials reporting positive effects in treating PTSD. We found MDMA currently has more promise than ketamine, based on the studies included in our review. It should be noted, though, that none of these four studies compared MDMA, in combination with psychotherapy, to a typical treatment for PTSD.

PTSD and psychoactive drugs: MDMA treatment shows potential, but others lack evidence Better known as the recreational drug ecstasy, MDMA may also play a valuable role in the treatment of PTSD and other mental health problems. Shutterstock

The MDMA studies in the review found that improvements in clinician-rated PTSD symptoms, and in self-reported physical responses to stress, were “significantly greater” for those who received MDMA and psychotherapy compared to a placebo. A small trial showed that 17-74 months after MDMA and therapy was delivered, on average, improvements were still being felt.

Another slightly larger trial involved military veterans, firefighters and police officers with chronic PTSD, and found a significant reduction in the severity of symptoms. Out of 24 participants who completed a 12-month follow-up, 16 did not have a PTSD diagnosis.

We also looked for research on the use of LSD and psilocybin in PTSD treatment, and were surprised to discover no randomised controlled trials have been conducted.

Where to from here?

Attitudes towards psychoactive drugs for the treatment of PTSD are changing. Some proponents suggest they offer a “chemical safety net” for patients.

However, our review highlights the fact that, scientifically, this area is still in its infancy. There is a clear need for further high quality research, to provide us with a better understanding of these treatments, and how they might fit into treatment options for PTSD.

Authors: Tracey Varker, Senior research fellow, Phoenix Australia, Department of Psychiatry, University of Melbourne

Read more https://theconversation.com/ptsd-and-psychoactive-drugs-mdma-treatment-shows-potential-but-others-lack-evidence-146092

Writers Wanted

Will I or won't I? Scientists still haven't figured out free will, but they're having fun trying


Total Recall at 30: why this brutal action film remains a classic


Industry cadetships: a good but small step to tap the talents of women in STEM


The Conversation


Prime Minister Interview with Kieran Gilbert, Sky News

KIERAN GILBERT: Kieran Gilbert here with you and the Prime Minister joins me. Prime Minister, thanks so much for your time.  PRIME MINISTER: G'day Kieran.  GILBERT: An assumption a vaccine is ...

Daily Bulletin - avatar Daily Bulletin

Did BLM Really Change the US Police Work?

The Black Lives Matter (BLM) movement has proven that the power of the state rests in the hands of the people it governs. Following the death of 46-year-old black American George Floyd in a case of ...

a Guest Writer - avatar a Guest Writer

Scott Morrison: the right man at the right time

Australia is not at war with another nation or ideology in August 2020 but the nation is in conflict. There are serious threats from China and there are many challenges flowing from the pandemic tha...

Greg Rogers - avatar Greg Rogers

Business News

AppDynamics Solves Visibility Gap Between Traditional Infrastructure and Cloud Environments

New Full Stack Observability Platform, Integration With Cisco Intersight Workload Optimizer and Cloud Native Visualisation Features Provide Cross Domain Insights and Analytics of Business Perfor...

Hotwire Global - avatar Hotwire Global

Why Your Small Business Should Bulk Buy Hand Sanitiser

As a small business owner, employee and customer safety is at the very top of your priority list. From risk assessments to health and safety officers, appropriate signage and proper briefing...

News Co - avatar News Co

How Phone Number Search In Sydney Can Help Your Business

To run a successful business, keeping track of your company and competitors are the major factors. With a lot of tools, available businesses have options to stay current. One way in which busine...

News Co - avatar News Co

News Co Media Group

Content & Technology Connecting Global Audiences

More Information - Less Opinion